Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-011385
Filing Date
2021-05-14
Accepted
2021-05-14 06:10:15
Documents
1
Period of Report
2011-05-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3464
  Complete submission text file 0001493152-21-011385.txt   4875
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 248 ROUTE 25A, NO. 2 EAST SETAUKET NY 11733
Business Address
Brown Regina (Reporting) CIK: 0001862089 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39717 | Film No.: 21921819